Boosting the immune system against COVID-19
Dr. Torsten Bohn, leader of the Nutrition and Health Research Group at the LIH Department of Population Health (DoPH), together with co-first authors Mohammed Iddir (PhD Student) and Dr. Alex Brito, recently published an article reviewing the importance of an optimal status of specific nutrients and additional dietary constituents to effectively aid in controlling inflammation and oxidative stress, thereby strengthening the immune system during the COVID-19 crisis.
Elucidating the roles of atypical chemokine receptors in cancer: from molecular biology to clinical relevance and therapy
Max Meyrath, Dr Andy Chevigné and Dr Martyna Szpakowska from the Immuno-Pharmacology and Interactomics research group of the Department of Infection and Immunity (DII) published a book chapter on cancer signalling, in collaboration with international partners. The scientific publication, which was released in February 2020 in Advances in Cancer Research, reviews the roles of atypical chemokine receptors (ACKRs) in the different phases of cancer development, progression and metastasis, their clinical relevance, as well as their implications for cancer therapy.
Second FNR COVID-19 Fast Track Call results
On Friday, May 29th, the Luxembourg National Research Fund (Fonds National de la Recherche - FNR) announced the results of the second round of financing under its novel COVID-19 Fast Track Call. A total of 21 out of the 55 eligible projects were retained for funding, corresponding to an FNR commitment of EUR 1.12 million. Namely, four LIH projects are among the selected ones, for a total support amounting to over EUR 197,000.
Predi-COVID - Behind the scenes
On April 24th, the Research Luxembourg Taskforce officially launched “Predi-COVID” (Luxembourg cohort of positive patients for COVID-19: a stratification study to predict severe prognosis»), a study led by the Department of Population Health (DoPH) of the Luxembourg Institute of Health (LIH).
CON-VINCE study results – second testing phase
CON-VINCE, a national research project aiming to evaluate the prevalence and dynamics of the spread of COVID-19 within the Luxembourgish population, was launched at the beginning of April under the umbrella of the Research Luxembourg COVID-19 Task Force.
[Article series] The experts behind Luxembourg’s Covid-19 fight
Prof Rejko Krüger is the Director of Transversal Translational Medicine (TTM) at LIH.
CON-VINCE Study - Behind the scenes (PART I)
On 8th April, the CON-VINCE study was officially launched, with the aim to assess the spread dynamics of the COVID-19 disease among the Luxembourgish population.
Large scale COVID-19 testing
As part of the deconfinement, Luxembourg is calling on its residents and cross-border workers to get tested for COVID-19. It aims to limit the spread of the novel corona virus by voluntary extensive testing until the end of July. This will allow to break infection chains and thus protect family, friends and colleagues. The more tests are carried out, the more new infections can be prevented and the safer everyday life will be.